Torr Metals Mobilizes Crews to Filion Gold Project, Testing Major Expansion Potential Along Trans-Canada Highway 11

VANCOUVER, British Columbia, Oct. 16, 2024 (GLOBE NEWSWIRE) — via IBN — Torr Metals Inc. (“Torr” or the “Company“) (TSX-V: TMET.V) is pleased to announce the mobilization of field crews to undertake a large-scale surface exploration program, consisting of soil sampling and prospecting, at its 100%-owned 261 km(2) Filion Gold Project (the “Project”) in northern […]

Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to VCN-01 for the Treatment of Retinoblastoma

ROCKVILLE, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) — Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that the European Commission has adopted the European Medicines Agency (EMA) recommendation to grant orphan medicinal product designation

Gentherm to Participate in the 2024 Baird Global Industrial Conference

NORTHVILLE, Mich., Oct. 16, 2024 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Phil Eyler, President and CEO will participate in a fireside chat at the 2024 Baird Global

Spinogenix Announces Launch of Glaucoma Program and Addition of World-Renowned Expert Dr. Robert Weinreb to its Science Advisory Board

LOS ANGELES, Oct. 16, 2024 (GLOBE NEWSWIRE) — Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced that Dr. Robert N. Weinreb, MD, has joined its science advisory board (SAB). The addition of Dr. Weinreb, Chair and Distinguished Professor of Ophthalmology at University

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

NDA based on two Phase 3 studies of TNX-102 SL in fibromyalgia with statistically significant results on the primary endpoint of reducing widespread pain; generally well tolerated TNX-102 SL is a non-opioid, centrally acting analgesic, granted Fast Track designation by FDA Fibromyalgia affects more than 10 million adults in the U.S. who are mostly women

The Vita Coco Company to Report Third Quarter 2024 Financial Results on October 30, 2024

NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today announced that it will report financial results for the third quarter ended September 30, 2024 on Wednesday, October 30, 2024 before market open. The Company will

The Chefs’ Warehouse to Announce Third Quarter Results on October 30, 2024

RIDGEFIELD, Conn., Oct. 16, 2024 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) today announced that the Company intends to release its financial results for the third quarter ended September 27, 2024 before the opening of the stock market on Wednesday, October 30, 2024 and host a conference call at 8:30 a.m. ET on

Forge Nano Receives $10M Investment from GM Ventures to Pursue GM Battery Material Enhancements for Future Electric Vehicles

Capital investment into Forge Nano now exceeds $100M; GM joins VW, LG, Hanwha and Mitsui Kinzoku as shareholders GM plans to utilize Forge Nano’s Atomic Armor surface engineering platform technology to pursue battery cathode material enhancements DENVER, Oct. 16, 2024 (GLOBE NEWSWIRE) — Forge Nano, Inc., a materials science company that uses its Atomic Armor(TM)

Verisk CEO Lee Shavel Appointed to Federal Advisory Committee on Insurance

JERSEY CITY, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, today announced that its president and CEO, Lee Shavel, has been appointed to the Federal Advisory Committee on Insurance (FACI). FACI provides advice and recommendations to assist the Federal Insurance Office (FIO) within the U.S.

Scroll to Top